14 July 2016 | Geneva −−The World Health Organization (WHO) is leading an effort to leverage routine leishmaniasis surveillance data from 25 high-burden countries from WHO regions to create new profiles.
The data include breakdown of new, relapse and imported cases; populations at risk; control and surveillance (including latest national guidelines, number of leishmaniasis health facilities), diagnosis (such as number of people screened, proportion of positive rapid diagnostic tests) and treatment including initial cure and case-fatality rates.
21 June 2016 | Geneva −− The World Health Organization (WHO) is supporting the use of a new data system to ensure the accurate, sustained flow of information for leishmaniasis. An improved dissemination and understanding of the problem posed by all forms of the disease can greatly help control programmes and allow countries to improve their surveillance systems.
Data from 25 countries with high disease prevalence show an estimated 399 million people are at risk of cutaneous leishmaniasis in 11 countries, while 556 million are exposed to visceral leishmaniasis 12 countries.
2 June 2016 | Geneva –– The World Health Organization (WHO) plans to harmonize the forecasting, procurement and delivery of quality-assured antileishmanial medicines to affected countries.
Currently, partners and stakeholders who work in collaboration with WHO plan their procurement, storage and distribution independently.
A first Stakeholders Meeting recently held in Geneva agreed that a common platform can greatly improve coordination, planning, monitoring and quality of medicines.
Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014
Visceral leishmaniasis: control strategies and epidemiological situation update in East Africa
Kala-Azar elimination programme
Explore some of the issues surrounding visceral leishmaniasis in Africa and in India, and cutaneous leishmaniasis in South America. Watch the trailer of "A trilogy of injustice"